Bristol-Myers Squibb Company - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
BMY New York 2830 www.bms.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bristol-Myers Squibb Company

Sjogren's Syndrome Market Analysis Report 2025-2035 Featuring Novartis, Otsuka Pharmaceutical, Nicox, and Bristol Myers Squibb - Apr 22nd, 2026 4:04 am
Vulvar Cancer Market Global and Regional Analysis Report 2025-2035, Profiles of Merck & Co., Bristol Myers Squibb, and AstraZeneca - Apr 22nd, 2026 3:59 am
Geronimo Power commences operations at 270MW Blevins Solar Project - Apr 22nd, 2026 2:10 am
Why Dow Jones Stock Merck Skidded 4% — And Boosted A Key Rival - Apr 21st, 2026 2:15 pm
Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now? - Apr 21st, 2026 9:26 am
Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock - Apr 21st, 2026 7:40 am
Geronimo Power Announces Start of Operations at Blevins Solar - Apr 21st, 2026 6:00 am
Foundation Medicine Expands Existing Collaboration with Bristol Myers Squibb to Develop a Next-Generation Sequencing Companion Diagnostic to Identify Patients with Homozygous MTAP Deletion - Apr 21st, 2026 5:00 am
Eli Lilly Snags $7 Billion Cancer Deal To Rival Gilead, J&J, Others - Apr 20th, 2026 2:26 pm
Can BMY's Growth Portfolio Counter Legacy Drugs Decline in Q1? - Apr 20th, 2026 12:44 pm
BMY Stock: Analysts See 16% Upside and a Strong Buy - Apr 20th, 2026 8:50 am
TD Cowen Initiates on MapLight (MPLT); Says It’s Undervalued on Schizophrenia Alone - Apr 20th, 2026 8:48 am
Why Bristol Myers Squibb (BMY) is a Top Momentum Stock for the Long-Term - Apr 20th, 2026 7:50 am
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer - Apr 20th, 2026 6:00 am
Bristol-Myers Squibb Collaboration Adds New Dimension To Oncology Valuation Story - Apr 18th, 2026 7:11 pm
Can Myqorzo Drive Growth for Cytokinetics Amid Competition? - Apr 17th, 2026 11:37 am
Roche’s DAC investment; Big Pharma’s lavish CEO bumps - Apr 17th, 2026 2:00 am
Why Bristol Myers Squibb (BMY) Outpaced the Stock Market Today - Apr 16th, 2026 3:45 pm
Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs - Apr 16th, 2026 5:30 am
Will Breyanzi's Strong Uptake Help BMY Offset Generic Competition? - Apr 15th, 2026 12:59 pm